OCL Vision, a London, UK-based ophthalmology company, received a multi million pound investment from BGF.
The amount of the deal was not disclosed.
The transaction was led by Alistair Brew, Karolina Sokolowska and Dylan Kaye of BGF’s London investment team.
The company intends to use the funds for its new site rollouts and enable further organic growth through enhanced marketing and sales capabilities.
Founded by Ali Mearza, Allon Barsam, and Romesh Angunawela, who were later joined by Chien Wong, OCL Vision is an ophthalmic health care company delivering eye care services.
The company, which has recorded double-digit growth in patient numbers and revenue in 2024, currently has 12 surgeons and employs a wider team of 60. The group offers the full spectrum of specialist ophthalmic procedures across two core segments: elective procedures, including laser vision correction and refractive lens replacement, as well as essential clinical procedures including cataract, retinal, glaucoma and oculoplastic surgeries.
OCL, which delivers almost 4,000 elective and clinical private procedures every year, recently strengthened its executive team, appointing Nicholas Rudge as CEO and Darren Millington as CFO, with Suzanne Lawrence joining as non-executive Chair through BGF’s Talent Network.
FinSMEs
03/03/2025